Understanding the mechanism of action of bacterial superantigens from a decade of research

Immunological Reviews

Volumn 168, Issue , 1999, Pages 257-269

  Lavoie, Pascal M ^a,b   Thibodeau, Jacques ^c   Erard, François ^a   Sékaly, Rafick Pierre ^a,b,c,d  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; STAPHYLOCOCCUS ENTEROTOXIN; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR;

ADAPTATION; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; BINDING AFFINITY; CROSS LINKING; HUMAN; HUMAN CELL; IMMUNE SYSTEM; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SEQUENCE HOMOLOGY; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, BACTERIAL; CLONAL ANERGY; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; RECEPTORS, ANTIGEN, T-CELL; SUPERANTIGENS;

EID: 0033054709     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1999.tb01297.x     Document Type: Review

References (143)

1. 1. Choi Y, Kappler JW, Marrack P. A superantigen encoded in the open reading frame of the 3' long terminal repeat of mouse mammary tumour virus. Nature 1991;350:203-207.
2. 2. White J, Herman A, Pullen AM, Kubo RT, Kappler JW, Marrack P. The Vβ-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 1989;56:27-35.
3. 3. Bergdoll MS. The staphylococcal enterotoxins - an update. In: Fisher G, ed. The staphylococci. New York: Springer Verlag; p. 1985. 247-254.
4. 4. Bohach GA, Stauffacher CV, Ohlendorf DH, Chi YI, Vath GM, Schlievert PM. The staphylococcal and streptococcal pyrogenic toxin family. Adv Exp Med Biol 1996;391:131-154.
5. 5. Fleischer B, Schrezenmeier H. T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory cells. J Exp Med 1988;167:1697-1707.
6. 6. Fleischer B, Gerlach D, Fuhrmann A, Schmidt KH. Superantigens and pseudosuperantigens of gram-positive cocci. Med Microbiol Immunol 1995;184:1-8.
7. 7. Fleischer B. Too many superaritigens. In: Thibodeau J, Sékaly R-P, eds. Bacterial superantigens: structure function and therapeutic potential. Austin: R. G. Landes Company; 1995. p. 25-38.
8. 8. Proft T, Moffat SL, Berkahn CJ, Fraser JD. Identification and characterization of novel superantigens from Streptococcus pyogenes. J Exp Med 1999;189:89-101.
9. 9. Nelson K, Schlievert PM, Selander RK, Musser JM. Characterization and clonal distribution of four alleles of the speA gene encoding pyrogenic exotoxin A (scarlet fever toxin) in Streptococcus pyogenes. J Exp Med 1991;174:1271-1274.
10. 10. Ramamurthy T, Yoshino K, Abe J, Ikeda N, Takeda T. Purification, characterization and cloning of a novel variant of the superantigen Yersinia pseudotuberculosis-derived mitogen. FEBS Lett 1997;413:174-176.
11. 11. Edwards VM, et al. Characterization of the canine type C enterotoxin produced by Staphylococcus intermedius pyoderma isolates. Infect Immun 1997;65:2346-2352.
12. 12. Stevens KR, et al. Species-dependent post-translational modification and position 2 allelism: effects on streptococcal superantigen SSA structure and V β specificity. J Immunol 1996;157:2479-2487.
13. 13. Acha-Orbea H, MacDonald HR. Superantigens of mouse mammary tumor virus. Annu Rev Immunol 1995;13:459-486.
14. 14. Lafon M, Scott-Algara D, Marche PN, Cazenave P-A, Jouvin-Marche E. Neonatal deletion and selective expansion of mouse T cells by exposure to rabies virus nucleocapsid superantigen. J Exp Med 1994;180:1207-1215.
15. 15. Tripp RA, et al. Pathogenesis of an infectious mononucleosis-like disease induced by a murine γ-herpesvirus: role for a viral superantigen? J Exp Med 1997;185:1641-1650.
16. 16. Sutkowski N, Palkama T, Ciurli C, Sékaly R-P, Thorley-Lawson DA, Huber BT. An Epstein-Barr virus-associated superantigen. J Exp Med 1996;184:971-980.
17. 17. Stuart PM, Woodward JG. Yersinia enterolitica produces superantigenic activity. J Immunol 1992;148:225-233.
18. 18. Stuart PM, Munn RK, DeMoll E, Woodward JG. Characterization of human T-cell responses to Yersinia enterocolitica superantigen. Hum Immunol 1995;43:269-275.
19. 19. Ohmen JD, Barnes PF, Grisso CL, Bloom BR, Modlin RL. Evidence for a superantigen in human tuberculosis. Immunity 1994;1:35-43.
20. 20. Yao Z, Maraskovsky E, Spriggs MK, Cohen JI, Armitage RJ, Alderson MR. Herpesvirus saimiri open reading frame 14, a protein encoded by T lymphotropic herpesvirus, binds to MHC class II molecules and stimulates T cell proliferation. J Immunol 1996;156:3260-3266.
21. 21. Denkers EY, Caspar P, Hieny S, Sher A. Toxoplasma gondii infection induces specific nonresponsiveness in lymphocytes bearing the Vβ5 chain of the mouse T cell receptor. J Immunol 1996;156:1089-1094.
22. 22. Pied S, et al. Evidence for superantigenic activity during murine malaria infection. Int Immunol 1997;9:17-25.
23. 23. Fell AH, Silins SL, Baumgarth N, Good MF. Plasmodium lalciparum-specific T cell clones from non-exposed and exposed donors are highly diverse in TCR β chain V segment usage. Int Immunol 1996;8:1877-1887.
24. + T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature 1991;349:245-248.
25. 25. Fraser JD, Newton ME, Weiss A. CD28 and T cell antigen receptor signal transduction coordinately regulate interleukin 2 gene expression in response to superantigen stimulation. J Exp Med 1992;175:1131-1134.
26. 26. Saha B, Harlan DM, Lee KP, June CH, Abe R. Protection against lethal toxic shock by targeted disruption of the CD28 gene. J Exp Med 1996;183:2675-2680.
27. 27. Herrmann T, MacDonald HR. The CD8 T cell response to staphylococcal enterotoxins. Semin Immunol 1993;5:33-39.
28. 28. Dohlsten M, Hedlund G, Kalland T. Staphylococcal-enterotoxin-dependent cell-mediated cytotoxicity. Immunol Today 1991;12:147-150.
29. 29. Viola A, Lanzavecchia A. T-cell activation determined by T cell receptor number and tunable thresholds. Science 1996;273:104-106.
30. 30. Leder L, al. A mutational analysis of the binding of staphylococcal enterotoxin B and C, to the T-cell receptor β chain and major histocompatibility complex class II. J Exp Med 1998;187:823-833.
31. + T cells by staphylococcal enterotoxin B. J Exp Med 1990;172:1091-1100.
32. + T cells in Staphylococcus enterotoxin B-primed mice. J Exp Med 1990;172:1065-1070.
33. 33. Grossman D, Van M, Mollick JA, Highlander SK, Rich RR. Mutation of the disulphide loop in staphylococcal enterotoxin A. Consequences for T cell recognition. J Immunol 1991;147:3274-3281.
34. 34. Schad EM, et al. Crystal structure of the superantigen staphylococcal enterotoxin type A. EMBO J 1995;14:3292-3301.
35. 2+ at 2.7 Ā resolution - implications for major histocompatibility complex class II binding. J Biol Chem 1996;271:32212-32216.
36. 36. Swaminathan S, Furey W, Pletcher J, Sax M. Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature 1992;359:801-806.
37. 37. Papageorgiou AC, Tranter HS, Acharya KR. Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5 A resolution: implications for superantigen recognition by MHC class II molecules and T-cell receptors. J Mol Biol 1998;277:69-77.
38. 2 from Staphylococcus aureus reveals a zinc-binding site. Structure 1995;3:769-779.
39. 39. Fields BA, et al. Crystal structure of a T-cell receptor β-chain complexed with a superantigen. Nature 1996;384:188-192.
40. 3+-mediated homodimerization. EMBO J 1996;15:6832-6840.
41. 41. Prasad GS, Earhart CA, Murray DL, Novick RP, Schlievert PM, Ohlendorf DH. Structure of toxic shock syndrome toxin 1. Biochemistry 1993;32:13761-13766.
42. 42. Acharya KR, et al. Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1. Nature 1994;367:94-97.
43. 43. Vath GM, et al. The structure of the superantigen exfoliative toxin A suggests a novel regulation as a serine protease. Biochemistry 1997;36:1559-1566.
44. 44. Papageorgiou AC, et al. Structural basis for the recognition of superantigen streptococcal pyrogenic exotoxin A (SpeA1) by MHC class II molecules and T-cell receptors. EMBO J 1999;18:9-21.
45. 45. Roussel A, Anderson BF, Baker HM, Fraser JD, Baker EN. Crystal structure of the streptococcal superantigen SPE-C: dimerization and zinc binding suggest a novel mode of interaction with MHC class II molecules. Nat Struct Biol 1997;4:635-643.
46. 46. Sundberg E, Jardetzky TS. Structural basis for the HLA-DQ binding by the streptococcal superantigen SSA. Nat Struct Biol 1999;6:123-129.
47. 47. Jardetzky TS, et al. Three-dimensional structure of human class II histocompatibility molecule complexed with superantigen. Nature 1994;368:711-718.
48. 48. Kappler JW, Herman A, Clements J, Marrack P. Mutations defining functional regions of the superantigen staphylococcal enterotoxin B. J Exp Med 1992;175:387-396.
49. 49. Thibodeau J, et al. Subsets of HLA-DR1 molecules defined by SEB and TSST-1 binding. Science 1994;266:1874-1878.
50. 50. Kim J, Urban RG, Strominger JL, Wiley DC. Crystallographic structure of toxic shock syndrome toxin-1 complexed with a human class II major histocompatibility molecule HLA-DR1. Science 1994;266:1870-1874.
51. 51. Karp DR, Teletski CL, Scholl P, Geha R, Long EO. The α1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1. Nature 1990;346:474-476.
52. 52. Braunstein NS, Weber DA, Wang X-C, Long EO, Karp D. Sequences in both class II major histocompatibility complex α and β chains contribute to the binding of the superantigen toxic shock syndrome toxin 1. J Exp Med 1991;175:1301-1305.
53. 53. Panina-Bordignon P, Fu X, Lanzavecchia A, Karr RW. Identification of HLA-DR α chain residues critical for binding of the toxic shock syndrome toxin superantigen. J Exp Med 1992;176:1779-1784.
54. 54. Seth A, et al. Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro. Nature 1994;369:324-327.
55. 55. Teng MK, et al. Identification of a common docking topology with substantial variation among different TCR-peptide MHC complexes. Curr Biol 1998;8:409-412.
56. 56. Ding YH, Smith KJ, Garboczi DN, Utz U, Biddison WE, Wiley DC. Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. Immunity 1998;8:403-411.
57. 57. Li PL, Tiedemann RE, Moffat SL, Fraser JD. The superantigen streptococcal pyrogenic exotoxin C (SPE-C) exhibits a novel mode of action. J Exp Med 1997;186:375-383.
58. 58. Mehindate K, Thibodeau J, Dohlsten M, Kalland T, Sékaly R-P, Mourad W. Cross-linking of major histocompatibility complex class II molecules by staphylococcal enterotoxin A superantigen is a requirement for inflammatory cytokine gene expression. J Exp Med 1995;182:1573-1577.
59. 59. Hargreaves REG, Brehm RD, Tranter H, Warrens AN, Lombardi G, Lechler RI. Definition of sites on HLA DR1 involved in the T cell response to staphylococcal enterotoxins E and C2. Eur J Immunol 1995;25:3437-3444.
60. 60. Al-Daccak R, Mehindate K, Hebert J, Rink L, Mecheri S, Mourad W. Mycoplasma arthritidis-derived superantigen induces proinflammatory monokine gene expression in the THP-1 human monocytic cell line. Infect Immun 1994;62:2409-2416.
61. 61. Hudson KR, Tiedemann RE, Urban RG, Lowe SC, Strominger JL, Fraser JD. Staphylococcal enterotoxin A has two cooperative binding sites on major histocompatibility complex class II. J Exp Med 1995;182:711-720.
62. 62. Tiedemann RE, Fraser JD. Cross linking of MHC class II molecules by staphylococcal enterotoxin A is essential for antigen-presenting cell and T cell activation. J Immunol 1996;157:3958-3966.
63. 63. Abrahmsén L, Dohlsten M, Segren S, Bjork P, Jonsson E, Kalland T. Characterization of two distinct MHC class II binding sites in the superantigen staphylococcal enterotoxin A. EMBO J 1995;14:2978-2986.
64. 64. Krakauer T, Oppenheim JJ. IL-1 and tumor necrosis factor-α each up-regulate both the expression of IFN-γ receptors and enhance IFN γ induced HLA-DR expression on human monocytes and a human monocytic cell line (THP-1). J Immunol 1993;150:1205-1211.
65. 65. Newton DW, et al. Mutations in the MHC class II binding domains of staphylococcal enterotoxin A differentially affect T cell receptor Vβ specificity. J Immunol 1996;157:3988-3994.
66. 66. Thibodeau J, et al. Molecular characterization and role in T cell activation of staphylococcal enterotoxin A binding to the HLA-DRα chain. J Immunol 1997;158:3698-3704.
67. 67. Nabavi N, Freeman GJ, Gault A, Godfrey D, Nadler LM, Glimcher LH. Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature 1992;360:266-268.
68. + T cells. J Exp Med 1991;173:759-762.
69. 69. Thibodeau J, Lavoie PM, Cazenave PA. "Bazinc" instinct: how SEA attracts MHC class II molecules. Res Immunol 1997;148:217-229.
70. 70. Herrmann T, Accolla RS, MacDonald HR. Different staphylococcal enterotoxins bind preferentially to distinct major histocompatibility complex class II isotypes. Eur J Immunol 1989;19:2171-2174.
71. 71. Lavoie PM, Thibodeau J, Cloutier I, Busch R, Sékaly R-P. Selective binding of bacterial toxins to major histocompatibility complex class II expressing cells is controlled by invariant chain and HLA-DM. Proc Natl Acad Sci USA 1997;94:6892-6897.
72. 72. Kozono H, Parker D, White J, Marrack P, Kappler J. Multiple binding sites for bacterial superantigens on soluble class II major histocompatibility complex molecules. Immunity 1995;3:187-196.
73. 73. Wen R, Cole GA, Surman S, Blackman MA, Woodland DL. Major histocompatibility complex class II-associated peptides control the presentation of bacterial superantigens to T cells. J Exp Med 1996;183:1083-1092.
74. 74. Wen R, Broussard DR, Surman S, Hogg TL, Blackman MA, Woodland DL. Carboxy-terminal residues of major histocompatibility complex class II-associated peptides control the presentation of the bacterial superantigen toxic shock syndrome toxin-1 to T cells. Eur J Immunol 1997;27:772-781.
75. 75. Rabourdin-Combe C, Mach B. Expression of HLA-DR antigens at the surface of mouse I. cells co transfected with cloned human genes. Nature 1983;303:670-674.
76. 76. Vidal K, Samarut C, Magaud J-P, Revillard J-P, Kaiserlian D. Unexpected lack of reactivity of allogeneic anti-Ia monoclonal antibodies with MHC class II molecules expressed by mouse intestinal epithelial cells. J Immunol 1993;151:4642-4650.
77. 77. Yagi J, Uchiyama T, Janeway CA Jr. Stimulator cell type influences the response of T cells to staphylococcal enterotoxins. J Immunol 1994;151:1154-1162.
78. 78. Shoukry NH, Lavoie PM, Thibodeau J, D'Souza S, Sékaly R-P. MHC class II-dependent peptide antigen versus superantigen presentation to T-cells. Hum Immunol 1997;54:194-201.
79. 79. Lightstone L, et al. In the absence of the invariant chain, HLA-DR molecules display a distinct array of peptides which is influenced by the presence or absence of HLA-DM. Proc Natl Acad Sci USA 1997;94:5772-5777.
80. 80. Lavoie PM, Sékaly R-P, Thibodeau J, Denis F. Interaction of superantigens with MHC class II molecules. In: Huber BT, Leung DYM, Schlievert PM, eds. Superantigens: structure, biology and relevance to human disease. New York: Marcel Dekker Inc; 1997; p. 61-84.
81. 81. Bohach GA, Kreiswirth BN, Novick RP, Schlievert PM. Analysis of toxic shock syndrome isolates producing staphylococcal enterotoxin B and C1 with use of southern hybridization and immunologic assays. Rev Infect Dis 1989;11:S75-S81.
82. 82. De Boer ML, Chow AW. Toxic shock syndrome toxin 1-producing Staphylococcus aureus isolates contain the staphylococcal enterotoxin B genetic element but do not express staphylococcal enterotoxin B. J Infect Dis 1994;170:818-827.
83. 83. Bonventre PF, Weckbach L, Harth G, Haidaris C. Distribution and expression of toxic shock syndrome toxin 1 gene among Staphylococcus aureus isolates of toxic shock syndrome and non toxic shock syndrome origin. Rev Infect Dis 1989;11:S90-S95.
84. 84. Herrmann T, et al. Staphylococcal enterotoxin-dependent lysis of MHC class II negative target cells by cytolytic T lymphocytes. J Immunol 1991;146:2504-2512.
85. 85. Cantor H, et al. Immunoregulatory effects of superantigens: interactions of staphylococcal enterotoxins with host MHC and non-MHC products. Immunol Rev 1993;131:27-42.
86. 86. Dohlsten M. al. Human major histocompatibility complex class II-negative colon carcinoma cells present staphylococcal superantigens to cytotoxic T lymphocytes: evidence for a novel enterotoxin receptor. Eur J Immunol 1991;21:1229-1233.
87. 87. Lamphear JG, Bohach GA, Rich RR. Structural dichotomy of staphylococcal enterotoxin C superantigens leading to MHC class II-independent activation of T lymphocytes. J Immunol 1998;160:2107-2114.
88. 88. Avery AC, Markowitz JS, Grusby MJ, Glimcher LH, Cantor H. Activation of T cells by superantigen in class II-negative mice. J Immunol 1994;153:4853-4861.
89. 89. Choi Y, Herman A, DiGiusto D, Wade T, Marrack P, Kappler JW. Residues of the variable region of the T cell receptor β-chain that interact with S. aureus toxin superantigens. Nature 1990;346:471-473.
90. 90. Rust CJJ, Verreck F, Victor H, Koning F. Specific recognition of staphylococcal enterotoxin A by human T cells bearing receptors with the Vγ-9 region. Nature 1990;346:572-574.
91. 91. Li H, Llera A, Mariuzza RA. Structure-function studies of T-cell receptor-superantigen interactions. Immunol Rev 1998;163:177-186.
92. 92. Irwin MJ, Hudson KR, Fraser JD, Gascoigne NRJ. Enterotoxin residues determining T-cell receptor Vβ binding specificity. Nature 1992;359:841-843.
93. 93. Swaminathan S, Furey W, Pletcher J, Sax M. Residues defining Vβ specificity in staphylococcal enterotoxins. Nat Struct Biol 1995;2:680-686.
94. 94. Braden BC, Goldman ER, Mariuzza RA, Poljak RJ. Anatomy of an antibody molecule: structure, kinetics, thermodynamics and mutational studies of the antilysozyme antibody D1.3. Immunol Rev 1998;163:45-57.
95. 95. Lyons DS, et al. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity 1996;5:53-61.
96. 96. Davis MM, et al. Ligand recognition by αβ T cell receptors. Annu Rev Immunol 1998;16:523-544.
97. 97. Gascoigne NRJ, Ames KT. Direct binding of secreted T-cell receptor β chain to superantigen associated with class II major histocompatibility complex protein. Proc Natl Acad Sci USA 1991;88:613-616.
98. 98. Malchiodi EL, et al. Superantigen binding to a T cell receptor β chain of known three-dimensional structure. J Exp Med 1995;182:1833-1845.
99. 99. Valitutti S, Lanzavecchia A. Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition. Immunol Today 1997;18:299-304.
100. 100. Alam SM, et al. T-cell-receptor affinity and thymocyte positive selection. Nature 1996;381:616-620.
101. + T cells. J Exp Med 1997;185:641-651.
102. 102. Surman S, Deckhut AM, Blackman MA, Woodland DL. MHC-specific recognition of a bacterial superantigen by weakly reactive T cells. J Immunol 1994;152:4893-4902.
103. 103. Deckhut AM, Chien Y-H, Blackman MA, Woodland DL. Evidence for a functional interaction between the β chain of major histocompatibility complex class II and the T cell receptor α chain during recognition of a bacterial superantigen. J Exp Med 1994;180:1931-1935.
104. 104. Labrecque N, Thibodeau J, Mourad W, Sékaly R-P. T cell receptor-major histocompatibility complex class II interaction is required for the T cell response to bacterial superantigens. J Exp Med 1994;180:1921-1929.
105. 105. Gascoigne NRJ, Alam SM, Haarstad CA, Sim B-C. Structural features of T-cell receptor recognition of superantigens. In: Thibodeau J. Sékaly R-P, eds. Bacterial superantigens: structure, fiuiction and therapeutic potential. Austin: R. G. Landes Company; 1995. p. 97-112.
106. 106. Lussow AR, MacDonald HR. Differential effects of superantigen-induced "anergy" on priming and effector stages of a T cell-dependent antibody response. Eur J Immunol 1994;24:445-449.
107. 107. Marrack P, Blackman M, Kushnir E, Kappler J. The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J Exp Med 1990;171:455-464.
108. 108. Ulevitch RJ, Tobias PS. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 1995;13:437-457.
109. 109. Renno T, Hahne M, Tschopp J, MacDonald HR. Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and upregulate Fas and Fas ligand. J Exp Med 1996;183:431-437.
110. 110. Miethke T, Wahl C, Heeg K, Echtenacher B, Krammer PH, Wagner H. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J Exp Med 1992;175:91-98.
111. 111. Dhein J, Walczak H, Baumler C, Debatin KM, Krammer PH. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 1995;373:438-441.
112. 112. Lenardo MJ. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 1991;353:858-861.
113. 113. Alderson MR, et al. Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 1995;181:71-77.
114. 114. Renno T, Hahne M, MacDonald HR. Proliferation is a prerequisite for bacterial superantigen-induced T cell apoptosis in vivo. J Exp Med 1995;181:2283-2287.
115. 115. O'Hehir RE, Lamb JR. Induction of specific clonal anergy in human T lymphocytes by Staphylococcus aureus enterotoxins. Proc Natl Acad Sci USA 1990;87:8884-8888.
116. 116. Bonfoco E, et al. Inducible nonlymphoid expresion of fas ligand is responsible for superantigen-induced peripheral deletion of T cells. Immunity 1998;9:711-720.
117. + T cell function during in vivo memory or tolerance induction. Immunity 1998;8:581-590.
118. 118. Mountz JD, Baker TJ, Borcherding DR, Bluethmann H, Zhou T, Edwards CK 3. Increased susceptibility of fas mutant MRL-lpr/lpr mice to staphylococcal enterotoxin B-induced septic shock. J Immunol 1995;155:4829-4837.
119. 119. Kumar A, Moreau JL, Gilbert M, Theze J. Internalization of interleukin 2 (IL-2) by high affinity receptors is required for the growth of IL-2-dependent T cell lines. J Immunol 1987;139:3680-3684.
120. 120. Kotzin BL, Leung DYM, Kappler J, Marrack P. Superantigens and their potential role in human disease. Adv Immunol 1993;54:99-166.
121. 121. Roder BL, Eriksen NH, Nielsen LP, Slotsbjerg T, Rosdahl VT, Espersen F. No difference in enterotoxin production among Staphylococcus aureus strains isolated from blood compared with strains isolated from healthy carriers. J Med Microbiol 1995;42:43-47.
122. 122. Zhang WJ, et al. Lethal synergism between influenza infection and staphylococcal enterotoxin B in mice. J Immunol 1996;157:5049-5060.
123. 123. Sarawar SR, Blackman MA, Doherty PC. Superantigen shock in mice with an inapparent viral infection. J Infect Dis 1994;170:1189-1194.
124. 124. Chesney PJ, Bergdoll MS, Davis JP. The disease spectrum, epidemiology, and etiology of toxic shock syndrome. Annu Rev Microbiol 1984;38:315-338.
125. 125. Bergdoll MS, Crass BA, Reiser RF, Robbins RN, Davis JP. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet 1981;1:1017-1021.
126. 126. Conrad B, Weissmahr RN, Boeni J, Arcari R, Schuepbach J, Mach B. A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell 1997;90:303-313.
127. 127. Bachmann MF, et al. Peptide-induced T cell receptor down-regulation on naive T cells predicts agonist partial agonist properties and strictly correlates with T cell activation. Eur J Immunol 1997;27:2195-2203.
128. 128. Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990;248:705-711.
129. 129. Micusan VV, Thibodeau J. Superantigens of microbial origin. Semin Immunol 1993;5:3-11.
130. 130. De Alba YB, Cazenave PA, Marche PN. Bacterial superantigen specificities of mouse T cell receptor Vβ20. Eur J Immunol 1995;25:3425-3430.
131. 131. Fleischer B, Necker A, Leget C, Malissen B, Romagne F. Reactivity of mouse T-cell hybridomas expressing human Vβ gene segments with staphylococcal and streptococcal superantigens. Infect Immun 1996;64:987-994.
132. 132. Munson SH, Tremaine MT, Betley MJ, Welch RA. Identification and characterization of staphylococcal enterotoxin types G and I from Staphylococcus aureus. Infect Immun 1998;66:3337-3348.
133. 133. Ren K, et al. Characterization and biological properties of a new staphylococcal exotoxin. J Exp Med 1994;180:1675-1683.
134. 134. Tomai MA, Schlievert PM, Kotb M. Distinct T-cell receptor V β gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pep M5 protein. Infect Immun 1992;60:701-705.
135. 135. Stevens KR, Van M, Lamphear JG, Rich RR. Altered orientation of streptococcal superantigen (SSA) on HLA-DR1 allows unconventional regions to contribute to SSA Vβ specificity. J Immunol 1996;157:4970-4978.
136. 136. Mollick JA, Miller GG, Musser JM, Cook RG, Grossman D, Rich RR. A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. J Clin Invest 1993;92:710-719.
137. 137. Friedman SM, et al. Characterization of human T cells reactive with the Mycoplasma arthritidis-derived superantigen (MAM):generation of a monoclonal antibody against Vβ17. the T cell receptor gene product expressed by a large fraction of MAM-reactive human. J Exp Med 1991;174:891-900.
138. 138. Miyoshi-Akiyama T, Abe A, Kato H, Kawahara K, Narimatsu H, Uchiyama T. DNA sequencing of the gene encoding a bacterial superantigen, Yersinia pseudotuberculosis-derived mitogen (YPM), and cliaracterization of the gene produce, cloned YPM. J Immunol 1995;154:5228-5234.
139. 139. Ito Y, Abe J, Yoshino K, Takeda T, Kohsaka T. Sequence analysis of the gene for a novel superantigen produced by Yersinia pseudotuberculosis and expression of the recombinant protein. J Immunol 1995;154:5896-5906.
140. 140. Bowness P, Moss PAH, Tranter H, Bell JI, McMichael AJ. Clostridium perfringens enterotoxin is a superantigen reactive with human T cell receptors Vβ6.9 and Vβ22. J Exp Med 1992;176:893-896.
141. 141. Hudson KR, Robinson H. Fraser JD. Two adjacent residues in staphylococcal enterotoxins A and E determine T cell receptor Vβ specificity. J Exp Med 1993;177:175-184.
142. 142. Cole BC, et al. The sequence of the Mycoplosma arthritidis superantigen, MAM: identification of functional domains and comparison with microbiol superantigens and plant lectin mitrogens. J Exp Med 1996;183:1105-1110.
143. 143. Andersen PS, et al. Role of the T-cell receptor (TCR) a chain in stabilizing TCR-superantigen-MHC class II complexes. Immunity 1999;10:473-483.